Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Govoni

Showing results (191-200 of 254) with videos related to

Pageof 26
Sort By:
Annals of the Rheumatic Diseases|September 29, 2020
Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound studyGeorgios Filippou, Anna Scanu, Antonella Adinolfi, et al.
Joint Bone Spine|August 2, 2014
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA registerMarco Sebastiani, Maria Grazia Anelli, Fabiola Atzeni, et al.
Lupus Science & Medicine|May 4, 2026
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohortGreta Hulej, Federico Arru, Benedetta Bianchi, et al.
RMD Open|December 20, 2018
Systemic lupus erythematosus: state of the art on clinical practice guidelinesFarah Tamirou, Laurent Arnaud, Rosaria Talarico, et al.
Scientific Reports|October 13, 2025
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosusAlessandra Bortoluzzi, Antonio Marangoni, Ettore Silvagni, et al.
Medicine|August 13, 2015
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter StudyLorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.
Journal of Autoimmunity|October 2, 2021
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohortMariele Gatto, Francesca Saccon, Laura Andreoli, et al.
Clinical Reviews in Allergy & Immunology|January 20, 2016
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative GroupLorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.
Annals of the Rheumatic Diseases|July 3, 2026
Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroupsGonzalo Borrego-Yaniz, Vera Fuentes-Moreno, Lourdes Ortiz-Fernández, et al.
Journal of Autoimmunity|January 14, 2020
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictorsLuca Quartuccio, Milena Bond, Miriam Isola, et al.
Pageof 26

Showing results (191-200 of 254) with videos related to

Sort By:
Pageof 26
Annals of the Rheumatic Diseases|September 29, 2020
Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound studyGeorgios Filippou, Anna Scanu, Antonella Adinolfi, et al.
Joint Bone Spine|August 2, 2014
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA registerMarco Sebastiani, Maria Grazia Anelli, Fabiola Atzeni, et al.
Lupus Science & Medicine|May 4, 2026
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohortGreta Hulej, Federico Arru, Benedetta Bianchi, et al.
RMD Open|December 20, 2018
Systemic lupus erythematosus: state of the art on clinical practice guidelinesFarah Tamirou, Laurent Arnaud, Rosaria Talarico, et al.
Scientific Reports|October 13, 2025
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosusAlessandra Bortoluzzi, Antonio Marangoni, Ettore Silvagni, et al.
Medicine|August 13, 2015
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter StudyLorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.
Journal of Autoimmunity|October 2, 2021
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohortMariele Gatto, Francesca Saccon, Laura Andreoli, et al.
Clinical Reviews in Allergy & Immunology|January 20, 2016
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative GroupLorenzo Cavagna, Laura Nuño, Carlo Alberto Scirè, et al.
Annals of the Rheumatic Diseases|July 3, 2026
Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroupsGonzalo Borrego-Yaniz, Vera Fuentes-Moreno, Lourdes Ortiz-Fernández, et al.
Journal of Autoimmunity|January 14, 2020
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictorsLuca Quartuccio, Milena Bond, Miriam Isola, et al.
Pageof 26